a year ago
SRPT
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Top 6%
#257 out of 5095 analysts
Average Return
+7.84%
Win Rate
40%178 out of 440
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celcuity IncCELC | +708.13% | $9.23 | $74.59 | 2025-04-10 - 2025-11-05 | Buy |
Celcuity IncCELC | +702.91% | $9.29 | $74.59 | 2025-03-31 - 2025-11-05 | Buy |
Celcuity IncCELC | +609.03% | $10.52 | $74.59 | 2025-05-14 - 2025-11-05 | Buy |
Novabridge BiosciencesNBP | +526.47% | $0.68 | $4.26 | 2025-04-03 - 2025-11-05 | Buy |
Celcuity IncCELC | +492.45% | $12.59 | $74.59 | 2025-02-05 - 2025-11-05 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
2 years ago
AUTL
2 years ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Geron CorpGERN | 23 | Buy | $4.00 | +266.97% | Maintains | a day ago |
Nurix Therapeutics IncNRIX | 27 | Buy | $26.00 | +108.75% | Reiterates | 2 days ago |
Tscan Therapeutics IncTCRX | 8 | Buy | $6.00 | +428.63% | Maintains | 2 days ago |
Autolus Therapeutics PLCAUTL | 31 | Buy | $10.00 | +622.02% | Reiterates | 3 days ago |
Celcuity IncCELC | 21 | Buy | $70.00 | -6.15% | Reiterates | 17 days ago |
Taysha Gene Therapies IncTSHA | 31 | Buy | $10.00 | +148.14% | Reiterates | 20 days ago |
Artiva Biotherapeutics IncARTV | 7 | Buy | $18.00 | +423.26% | Reiterates | 20 days ago |
Crispr Therapeutics AgCRSP | 25 | Buy | $81.00 | +42.13% | Reiterates | a month ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $14.00 | +52.34% | Upgrades | 2 months ago |
Recursion Pharmaceuticals IncRXRX | 25 | Buy | $8.00 | +61.29% | Reiterates | 2 months ago |
Novabridge BiosciencesNBP | 17 | Buy | $6.00 | +40.85% | Reiterates | 2 months ago |
Generation Bio CoGBIO | 18 | Buy | $15.00 | +189.02% | Reiterates | 3 months ago |
Nkarta IncNKTX | 17 | Buy | $10.00 | +412.82% | Reiterates | 3 months ago |
Absci CorpABSI | 5 | Buy | $8.00 | +109.97% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 33 | Hold | $50.00 | +167.81% | Downgrades | 4 months ago |
Mereo Biopharma Group PLCMREO | 19 | Buy | $5.00 | +177.78% | Maintains | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 21 | Hold | $42.00 | +1,165.06% | Downgrades | 5 months ago |
Cartesian Therapeutics IncRNAC | 23 | Buy | $40.00 | +421.51% | Maintains | 6 months ago |
Immunocore Holdings PLCIMCR | 14 | Buy | $71.00 | +130.52% | Reiterates | 7 months ago |
Arcellx IncACLX | 22 | Buy | $105.00 | +19.99% | Reiterates | a year ago |
Shattuck Labs IncSTTK | 13 | Hold | $8.00 | N/A | Downgrades | a year ago |
Nextcure IncNXTC | 9 | Buy | $48.00 | N/A | Reiterates | a year ago |
G1 Therapeutics IncGTHX | 17 | Buy | $6.00 | N/A | Maintains | a year ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Tectonic Therapeutic IncTECX | 4 | Buy | $72.00 | N/A | Reiterates | 3 years ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.